Julia White, MD, Discusses Tailored Local Therapy Treatment in Breast Cancer
The professor of radiation oncology discussed these tailored treatments for when patients receive neoadjuvant chemotherapy, and they get a complete pathologic response.
Related Articles
Elucidating the Clinical Landscape for Rare Lymphoma Treatment
Diagnostic developments using aberrances in biomarker testing may help enhance survival in patients with rare lymphoma subtypes.
Outlining Ongoing Clinical Developments in Treatment for Rare Lymphomas
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Rad Onc First to Dose 177Lu in US, Notes Enormity of Recent mCRPC Approval
After the recent approval of 177Lu in PSMA+/mCPRCP prior to chemotherapy, Steven Finkelstein, MD, DABR, FACRO, highlights the importance of this milestone.
Bexmarilimab/Chemo Yield Positive Responses in Myelodysplastic Syndromes
Topline results from the phase 1/2 BEXMAB trial showed “one of the strongest data sets ever seen” in treatment-resistant higher-risk MDS populations.
Bria-IMT Enhances Survival vs Sacituzumab Govitecan in HR+ Breast Cancer
No treatment-related discontinuations have been observed related to Bria-IMT treatment for hormone receptor–positive breast cancer.
FDA Approves Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC
The FDA approved nivolumab with ipilimumab in adult and pediatric patients with CRC based on data from the phase 3 CHECKMATE-8HW trial.
Advancing First-Line Treatment Strategies in Gastric and Esophageal Cancers
Panelists discuss how the 5-year survival data for nivolumab plus chemotherapy underscore its sustained efficacy as a first-line treatment, showing durable benefits over alternatives. Further…
From IMDC Risk Assessments to Sequencing Strategies: Clinical Implications From CLEAR Post Hoc Analyses
Experts discuss the clinical implications from CLEAR post hoc analyses, focusing on IMDC risk assessments and sequencing strategies.
Addressing Racial Disparities, Social Barriers to Breast Cancer Care
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer
Human saliva may hold antioxidants that are able to monitor the oral cavity’s oxidative processes and offer guidance for the development of new drugs.